Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry J Fry

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2016
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation RelapseNirali N Shah, David M Loeb, Hahn Khuu, et al.
Immunity|November 16, 2002
Bax deficiency partially corrects interleukin-7 receptor alpha deficiencyAnnette R Khaled, Wen Qing Li, Jiaqiang Huang, et al.
Journal of Translational Medicine|March 17, 2017
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cellsDavid F Stroncek, Daniel W Lee, Jiaqiang Ren, et al.
Transfusion|February 26, 2017
Autologous lymphapheresis for the production of chimeric antigen receptor T cellsElizabeth S Allen, David F Stroncek, Jiaqiang Ren, et al.
Blood|August 1, 2014
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHDChristian M Capitini, Nicole M Nasholm, Christopher D Chien, et al.
Molecular Therapy Oncolytics|December 25, 2018
Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22Haiying Qin, Sneha Ramakrishna, Sang Nguyen, et al.
Blood|September 14, 2018
Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptorHaiying Qin, Kazusa Ishii, Sang Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma KinaseAlec J Walker, Robbie G Majzner, Ling Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2011
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomasKristin Baird, Terry J Fry, Seth M Steinberg, et al.
Haematologica|August 11, 2022
Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against <i>FLT3</i>- mutant acute myeloid leukemia and <i>KMT2A</i>-rearranged acute lymphoblastic leukemiaLisa M Niswander, Zachary T Graff, Christopher D Chien, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2016
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation RelapseNirali N Shah, David M Loeb, Hahn Khuu, et al.
Immunity|November 16, 2002
Bax deficiency partially corrects interleukin-7 receptor alpha deficiencyAnnette R Khaled, Wen Qing Li, Jiaqiang Huang, et al.
Journal of Translational Medicine|March 17, 2017
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cellsDavid F Stroncek, Daniel W Lee, Jiaqiang Ren, et al.
Transfusion|February 26, 2017
Autologous lymphapheresis for the production of chimeric antigen receptor T cellsElizabeth S Allen, David F Stroncek, Jiaqiang Ren, et al.
Blood|August 1, 2014
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHDChristian M Capitini, Nicole M Nasholm, Christopher D Chien, et al.
Molecular Therapy Oncolytics|December 25, 2018
Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22Haiying Qin, Sneha Ramakrishna, Sang Nguyen, et al.
Blood|September 14, 2018
Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptorHaiying Qin, Kazusa Ishii, Sang Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma KinaseAlec J Walker, Robbie G Majzner, Ling Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 8, 2011
Reduced-intensity allogeneic stem cell transplantation in children and young adults with ultrahigh-risk pediatric sarcomasKristin Baird, Terry J Fry, Seth M Steinberg, et al.
Haematologica|August 11, 2022
Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against <i>FLT3</i>- mutant acute myeloid leukemia and <i>KMT2A</i>-rearranged acute lymphoblastic leukemiaLisa M Niswander, Zachary T Graff, Christopher D Chien, et al.
Pageof 13